John Cogan, COO, Qinecsa outlines the opportunity presented by AI-driven automation to transform pharmacovigilance, both to address soaring workloads and costs, and to inject new strategic purpose into the function’s role.
David Staunton, industry transformation leader at Cognizant Life Science Manufacturing shares how life sciences companies are under immense pressure to deliver new treatments to a global population faster.
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, is launching two complementary initiatives to transform pharmacovigilance (PV) in response to growing member demand.
Professor Philipp Koellinger, co-founder and CEO of open science startup DeSci Labs, argues that peer review needs urgent reform and that AI can help pharma live up to its ideals.
The SciY business has announced the integration of Optimal Industrial Technologies and Optimal Industrial Automation into the SciY Laboratory Digitalization Suite.
Qureight, a techbio company accelerating drug development using its proprietary deep-learning image biomarkers and clinical data analytics platform, has announced the first results from a collaboration with Insilico Medicine.
For too long, regulatory teams have become bogged down by protracted reviews of the regulatory implications. Generative AI (GenAI) promises to change all that, say independent consultant Preeya Beczek and Agnes Cwienczek of ArisGlobal.
OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, has been named a Gold Winner in the 2025 Merit Awards for Business in the Research and Development category.
Mark Fish, VP and GM of Digital Lab Solutions discusses the importance of making automation more accessible for labs across industries with the next generation of innovation.
Shift Bioscience (Shift), a company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, has announced the results of a study detailing an improved approach to ranking virtual cell models for gene discovery.
